• Consensus Rating: Buy
  • Consensus Price Target: GBX 170
  • Forecasted Upside: 26.87%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 134
▲ +3.5 (2.68%)

This chart shows the closing price for FVA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ForViva Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FVA

Analyst Price Target is GBX 170
▲ +26.87% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ForViva in the last 3 months. The average price target is GBX 170, with a high forecast of GBX 170 and a low forecast of GBX 170. The average price target represents a 26.87% upside from the last price of GBX 134.

This chart shows the closing price for FVA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in ForViva.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/13/2025Canaccord Genuity GroupInitiated CoverageBuyGBX 170
(Data available from 12/5/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

ForViva

Fevara plc is an international, pure-play specialist agriculture manufacturer and provider of research-proven, value-added livestock supplements. Fevara's mission is to drive sustainable global food security through enhancements to pasture grazing productivity, enabled by research-based products that optimise livestock performance and profitability for farmers. The Group produces nutritional animal supplements including feed licks, blocks, bagged minerals, and boluses for cattle, sheep, goats and horses. Its globally recognised brands include SmartLic, Crystalyx and Horslyx. Headquartered in Carlisle, Cumbria, Fevara operates 7 manufacturing sites across the UK, Germany and the USA, and serves customers in more than 20 countries through its expansive global distribution and support network. The Company has been listed on the London Stock Exchange since 1972. Fevara plc's ticker is "FVA". For more information, visit: https://www.fevara.com/
Read More

Today's Range

Now: GBX 134
Low: 134
High: 137.50

50 Day Range

MA: N/A

52 Week Range

Now: GBX 134
Low: 121
High: 139.50

Volume

368 shs

Average Volume

28,648 shs

Market Capitalization

£69.37 million

P/E Ratio

N/A

Dividend Yield

2.98%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ForViva?

The following sell-side analysts have issued stock ratings on ForViva in the last twelve months: Canaccord Genuity Group Inc..
View the latest analyst ratings for FVA.

What is the current price target for ForViva?

0 Wall Street analysts have set twelve-month price targets for ForViva in the last year. Their average twelve-month price target is GBX 170, suggesting a possible upside of 26.9%. Canaccord Genuity Group Inc. has the highest price target set, predicting FVA will reach GBX 170 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of GBX 170 for ForViva in the next year.
View the latest price targets for FVA.

What is the current consensus analyst rating for ForViva?

ForViva currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe FVA will outperform the market and that investors should add to their positions of ForViva.
View the latest ratings for FVA.